The Asia Pacific Healthcare Bioconvergence Market would witness market growth of 7.4% CAGR during the forecast period (2022-2028).
The examination of nature and its mechanics, models, and their application to the process of the invention is exactly what the Bioconvergence technique entails. This strategy has been gaining ground in the sciences, particularly the life sciences and medical innovation, and for a good cause.
It enables innovators to not only produce better goods and have a genuine impact but also to gain access to more and better capital, which facilitates the creation of these superior products' businesses and their commercialization. The aim to offer consumers better healthcare goods and services led to this amazing development in biosciences.
The healthcare system has undergone significant modifications and revisions recently in an effort to offer the world's population more affordable and efficient medical care. Researchers from all around the world have been examining how to use and mimic nature to treat the majority of the diseases that plague the global populace.
China's population is aging at one of the fastest rates in the world. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. For public health and socioeconomic development, this profound demographic shift creates a number of new challenges and opportunities. Of particular importance is the creation of an integrated system that meets the social and health needs of older people while ensuring that everyone has access to healthcare, regardless of location.
The China market dominated the Asia Pacific Engineered Living Materials Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $808.3 million by 2028. The Japan market is estimated to grow a CAGR of 8.1% during (2022 - 2028). Additionally, The India market would display a CAGR of 9.4% during (2022 - 2028).
Based on Application, the market is segmented into Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Healthcare Bioconvergence Market is Projected to reach USD 169.9 Billion by 2028, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BiomX, Inc., Singota Solutions, Anima Biotech Inc., Ginkgo Bioworks Holdings, Inc., SetPoint Medical Corporation, Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), and BICO Group AB (publ).
Scope of the Study
Market Segments Covered in the Report:
By Application
- Drug Discovery
- Precision Medicine
- Regenerative Medicine
- Diagnostic & Biological Sensors
- Bioelectronics
- Nanorobotics for Drug Delivery
- Engineered Living Materials
- Optogenetics
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- BiomX, Inc.
- Singota Solutions
- Anima Biotech Inc.
- Ginkgo Bioworks Holdings, Inc.
- SetPoint Medical Corporation
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- BICO Group AB (publ)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Healthcare Bioconvergence Market, by Application
1.4.2 Asia Pacific Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Healthcare Bioconvergence Market by Application
3.1 Asia Pacific Drug Discovery Market by Country
3.2 Asia Pacific Precision Medicine Market by Country
3.3 Asia Pacific Regenerative Medicine Market by Country
3.4 Asia Pacific Diagnostic & Biological Sensors Market by Country
3.5 Asia Pacific Bioelectronics Market by Country
3.6 Asia Pacific Nanorobotics for Drug Delivery Market by Country
3.7 Asia Pacific Engineered Living Materials Market by Country
3.8 Asia Pacific Optogenetics Market by Country
Chapter 4. Asia Pacific Healthcare Bioconvergence Market by Country
4.1 China Healthcare Bioconvergence Market
4.1.1 China Healthcare Bioconvergence Market by Application
4.2 Japan Healthcare Bioconvergence Market
4.2.1 Japan Healthcare Bioconvergence Market by Application
4.3 India Healthcare Bioconvergence Market
4.3.1 India Healthcare Bioconvergence Market by Application
4.4 South Korea Healthcare Bioconvergence Market
4.4.1 South Korea Healthcare Bioconvergence Market by Application
4.5 Singapore Healthcare Bioconvergence Market
4.5.1 Singapore Healthcare Bioconvergence Market by Application
4.6 Malaysia Healthcare Bioconvergence Market
4.6.1 Malaysia Healthcare Bioconvergence Market by Application
4.7 Rest of Asia Pacific Healthcare Bioconvergence Market
4.7.1 Rest of Asia Pacific Healthcare Bioconvergence Market by Application
Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview
TABLE 1 Asia Pacific Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 23 China Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 24 China Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 25 China Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 26 China Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 27 Japan Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 28 Japan Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 29 Japan Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 30 Japan Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 31 India Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 32 India Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 33 India Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 34 India Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 35 South Korea Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 36 South Korea Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 37 South Korea Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 38 South Korea Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 39 Singapore Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 40 Singapore Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 41 Singapore Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 42 Singapore Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 43 Malaysia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 44 Malaysia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 45 Malaysia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 46 Malaysia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 47 Rest of Asia Pacific Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 48 Rest of Asia Pacific Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 49 Rest of Asia Pacific Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 50 Rest of Asia Pacific Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 51 Key Information – BiomX, Inc.
TABLE 52 Key Information – Galvani Bioelectronics, Ltd.
TABLE 53 Key Information – BICO Group AB (publ)
TABLE 54 Key Information – Ginkgo Bioworks Holdings, Inc.
TABLE 55 Key Information – Singota Solutions
TABLE 56 Key Information – Anima Biotech Inc.
TABLE 57 Key Information – Setpoint Medical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: BICO Group AB (publ)